Acute renal failure in children and infants

Current Opinion in Critical Care

Volumn 10, Issue 6, 2004, Pages 499-504

  Barletta, Gina Marie ^a   Bunchman, Timothy E ^a  

^a HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

Acute renal failure; Citrate anticoagulation; Continuous renal replacement therapy; Dialysis; Hemofiltration; Pediatrics

Indexed keywords

ANTICOAGULANT AGENT; BICARBONATE; CALCIUM CHLORIDE; CITRIC ACID; DIURETIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NAFAMSTAT; PROSTACYCLIN;

ACUTE GLOMERULONEPHRITIS; ACUTE KIDNEY FAILURE; ANTICOAGULATION; ARTERY THROMBOSIS; BLEEDING; BLOOD TOXICITY; BLOOD VESSEL INJURY; CHILD; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY DYSPLASIA; KIDNEY FAILURE; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; MALIGNANT HYPERTENSION; METABOLIC ALKALOSIS; NUTRITIONAL SUPPORT; PYELONEPHRITIS; REVIEW; SIDE EFFECT; SOLITARY KIDNEY;

EID: 10244229089     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000144940.32521.de     Document Type: Review

References (55)

1. Benfield MR, Bunchman TE: Management of acute renal failure. In Pediatric Nephrology, 5th ed. Edited by Avner ED, Harmon WE, Niaudet P. Philadelphia: Lippincott Williams & Wilkins; 2004:1253-1288.
2. Andreoli SP: Acute renal failure in the newborn. Semin Perinatol 2004, 28:112-123. This is a comprehensive review of the etiologic factors and management of ARF during the newborn period and the different modes of dialysis in this patient population.
3. Maxvold NJ, Bunchman TE: Renal failure and renal replacement therapy. Crit Care Clin 2003, 19:563-575. This is a complete review of renal replacement therapy with perspectives from both a pediatric intensivist and pediatric nephrologist. This is a good source for review of CRRT anticoagulation.
4. Dutta S, Narang A: Enalapril-induced acute renal failure in a newborn infant. Pediatr Nephrol 2003, 18:570-572.
5. Singh SA, Nalini P, Badhe BA: Acute renal failure following snakebite in children. J Trop Pediatr 2003, 49:308-309.
6. Flynn JT: Causes, management approaches, and outcome of acute renal failure in children. Curr Opin Pediatr 1998, 10:184-189.
7. Rahman M, Hossain M: The bimodal mortality pattern of acute renal failure in children. Ren Fail 1993, 15:55-59.
8. Agarwal N, Phadke KD, Garg I, et al.: Acute renal failure in children with idiopathic nephrotic syndrome. Pediatr Nephrol 2003, 18:1289-1292.
9. Goldstein SL: Overview of pediatric renal replacement therapy in acute renal failure. Artif Organs 2003, 27:781-785. This paper discusses the epidemiology of pediatric ARF and management of particular patient populations.
10. Ronco C, Bellomo R: Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002, 25:733-747.
11. DiCarlo JV, Alexander SR, Agarwal R, et al.: Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy. J Pediatr Hematol Oncol 2003, 25:801-805. This article provides an intensivist's viewpoint of aggressive early management of patients with acute respiratory distress syndrome status-post bone marrow transplantation and chemotherapy.
12. Lin MC, Fu YC, Fu LS, et al.: Peritoneal dialysis in children with acute renal failure after open heart surgery. Acta Paediatr Taiwan 2003, 44:89-92.
13. Fleming F, Bohn D, Edwards H, et al.: Renal replacement therapy after repair of congenital heart disease in children. A comparison of hemofiltration and peritoneal dialysis. J Thorac Cardiovasc Surg 1995, 109:322-331.
14. Michael M, Kuehnle I, Goldstein SL: Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 2004, 19:91-95.
15. Denton MD, Chertow GM, Brady HR: "Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int 1996, 50:4-14.
16. Bellomo R, Chapman M, Finfer S, et al.: Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356:2139-2143.
17. Kellum JA: The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence. Crit Care 1997, 1:53-59.
18. Dellinger RP, Cartel JM, Masur H, et al.: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873. This is an excellent resource to aid in the management of sepsis. It provides recent guidelines describing interventions that improve the outcome in critically ill patients and also includes a section on specific pediatric considerations.
19. Kellum JA: Diuretics in acute renal failure: protective or deleterious. Blood Purif 1997, 15:319-322.
20. Lassnigg A, Donner E, Grubhofer G, et al.: Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000, 11:97-104.
21. Asif A, Epstein M: Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 2004, 44:12-24.
22. Flynn JT: Choice of dialysis modality for management of pediatric acute renal failure. Pediatr Nephrol 2002, 17:61-69.
23. van Bommel EF, Leunissen KM, Weimar W: Continuous renal replacement therapy for critically ill patients: an update. J Intensive Care Med 1994, 9:265-280.
24. D'Intini V, Ronco C, Bonello M, et al.: Renal replacement therapy in acute renal failure. Best Pract Res Clin Anaesthesiol 2004, 18:145-157.
25. Olowu WA: Renal failure in Nigerian children: factors limiting access to dialysis. Pediatr Nephrol 2003, 18:1249-1254.
26. Strazdins V, Watson AR, Harvey B: Renal replacement therapy for acute renal failure in children: European guidelines. Pediatr Nephrol 2004, 19:199-207. The authors provide practical guidelines for the use of renal replacement therapy in children and a discussion of associated complications.
27. Parakininkas D, Greenbaum LA: Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 2004, 5:269-274. This article provides a comparison of several different modes of CRRT with regard to clearance of low molecular weight molecules, using low blood flow rates in pediatric patients.
28. Bunchman TE, Maxvold NJ, Brophy PD: Pediatric convective hemofiltration: Normocarb® replacement fluid and citrate anticoagulation. Am J Kidney Dis 2003, 42:1248-1252. This is the first paper to discuss the use of a commercially produced bicarbonate-based replacement solution for convective hemofiltration.
29. Warady BA, Bunchman TE: Dialysis therapy for children with acute renal failure: survey results. Pediatr Nephrol 2000, 15:11-13.
30. Bunchman TE, Valentini RP, Gardner JJ, et al.: Treatment of vancomycin overdose using high-efficiency dialysis membranes. Pediatr Nephrol 1999, 13:773-774.
31. Brophy PD, Tenenbein M, Gardner JJ, et al.: Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor fomepizole and hemodialysis. Am J Kidney Dis 2000, 35:958-962.
32. Askenazi DJ, Goldstein SL, Chang IF, et al.: Management of a severe carbamazepine overdose using albumin-enhanced continuous venovenous hemodialysis. Pediatrics 2004, 113:406-409.
33. Ronco C, Brendolan A, Bragantini L, et al.: Treatment of acute renal failure in the newborn by continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 1985, 31:634-638.
34. Saccente SL, Kohaut EC, Berkow RL: Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol 1995, 9:569-573.
35. Falk MC, Knight JF, Roy LP, et al.: Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism. Pediatr Nephrol 1994, 8:330-333.
36. Parekh RS, Bunchman TE: Dialysis support in the pediatric intensive care unit. Adv Ren Replace Ther 1996, 3:326-336.
37. McBryde KD, Kudelka TL, Kershaw DB, et al.: Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency. J Pediatr 2004, 144:536-540. This article addresses the use of CRRT for management of pediatric patients with inborn errors of metabolism.
38. Hmiel SP, Martin RA, Landt M, et al.: Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration. Pediatr Crit Care Med 2004, 5:278-281. The use of CRRT for management of pediatric patients with inborn errors of metabolism is addressed.
39. Yap HJ, Chen YC, Fang JT, et al.: Combination of continuous renal replacement therapies (CRRT) and extracorporeal membrane oxygenation (ECMO) for advanced cardiac patients. Ren Fail 2003, 25:183-193.
40. Ronco C, Bellomo R, Homel P, et al.: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000, 356:26-30.
41. Barenbrock M, Hausberg M, Matzkies F, et al.: Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcomes in CVVH patients. Kidney Int 2000, 58:1751 -1757.
42. Bunchman TE, McBryde KD, Mottes TE, et al.: Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol 2001, 16:1067-1071.
43. Elhanan N, Skippen P, Nuthall G, et al.: Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 2004, 19:208-212. This is a good source for reviewing the use of regional citrate anticoagulation for CRRT in critically ill pediatric patients, with noted reduction in systemic bleeding complications.
44. Reeves JH, Cumming AR, Gallagher L, et al.: A controlled trial of low-molecular-weight heparin (Dalteparin) versus unfractionated heparin as anti-coagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 1999, 27:2224-2228.
45. Kozek-Langenecker SA, Kettner SC, Oismueller C, et al.: Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration. Crit Care Med 1998, 26:1208-1212.
46. Hiraide A, Tazaki O, Fujii N, et al.: Cardiac tamponade secondary to hemorrhagic pericarditis during continuous hemofiltration for renal failure. The role of the anticoagulant. Ren Fail 1994, 16:299-301.
47. Bunchman TE, Maxvold NJ, Barnett J, et al.: Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 2002, 17:150-154.
48. Meier-Kriesche HU, Gitomer J, Finkel K, et al.: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001, 29:748-752.
49. Maxvold NJ, Smoyer WE, Custer JR, et al.: Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000, 28:1161-1165.
50. Litwin M: Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol 2004, 19:178-186.
51. Symons JM, Brophy PD, Gregory MJ, et al.: Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 2003, 41:984-989. This study demonstrates the feasibility and usefulness of CRRT in small children (less than 10 kg) with discussion of outcomes and survival rates.
52. Abitbol CL, Bauer CR, Montane B, et al.: Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 2003, 18:887-893. The authors discuss the prognostic indicators for long-term outcome in a growing population of extremely low birth weight infants with renal failure.
53. Goldstein SL, Currier H, Graf CD, et al.: Outcome in children receiving continuous venovenous hemofiltration. Pediatrics 2001, 107:1309-1312.
54. Bunchman TE, Maxvold NJ, Kershaw DB, et al.: Continuous venovenous hemodiafiltration in infants and children. Am J Kidney Dis 1995, 25:17-21.
55. Goldstein SL, Somers MJG, Brophy PD, et al.: The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: design, development and data assessed. Int J Artif Organs 2004, 27:9-14. This article outlines and discusses the registry study aims, design, and data collection demographics as well as patient enrollment issues.